跳至主要内容
临床试验/ITMCTR2100004493
ITMCTR2100004493招募中未知

To investigate the molecular mechanism of sarcopenia based on AMPK/SIRT1 signaling pathway

The Third people's Hospital of Hangzhou0 个研究点开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
65 至 90(—)
性别
All

入选标准

  • 1. Conscious subjects;
  • 2. Subjects with certain understanding and activity ability;
  • 3. Subjects aged 65-90 years.

排除标准

  • 1. Patients with severe hepatic and renal insufficiency;
  • 2. Subjects with dementia;
  • 3. Subjects unable to participate in the investigation due to acute stroke, severe infection, acute myocardial infarction, severe heart failure and other diseases;
  • 4. Subjects unwilling to cooperate with the investigation;
  • 5. All patients did not take drugs that may affect the bone or metabolism.

研究者

发起方
The Third people's Hospital of Hangzhou

相似试验

Observation on the curative effect of Shenling... | 临床试验